Seven biotechs eye $2.3B in public offerings after data readouts
Seven biotechs eye $2.3B in public offerings after data readouts
本文は利用できません。元の情報源をご確認ください。
Seven biotechs eye $2.3B in public offerings after data readouts
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.